RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      검색결과 좁혀 보기

      선택해제
      • 좁혀본 항목 보기순서

        • 원문유무
        • 원문제공처
          펼치기
        • 등재정보
        • 학술지명
          펼치기
        • 주제분류
          펼치기
        • 발행연도
          펼치기
        • 작성언어

      오늘 본 자료

      • 오늘 본 자료가 없습니다.
      더보기
      • 무료
      • 기관 내 무료
      • 유료
      • KCI등재

        Limited Diagnostic Utility of Plasma Adrenocorticotropic Hormone for Differentiation between Adrenal Cushing Syndrome and Cushing Disease

        홍아람,김정희,홍은실,김이경,박경선,안창호,김상완,신찬수,김성연 대한내분비학회 2015 Endocrinology and metabolism Vol.30 No.3

        Background: Measurement of the plasma adrenocorticotropic hormone (ACTH) level has been recommended as the first diagnostic test for differentiating between ACTH-independent Cushing syndrome (CS) and ACTH-dependent CS. When plasma ACTH values are inconclusive, a differential diagnosis of CS can be made based upon measurement of the serum dehydroepiandrosterone sulfate (DHEA-S) level and results of the high-dose dexamethasone suppression test (HDST). The aim of this study was to assess the utility of plasma ACTH to differentiate adrenal CS from Cushing’ disease (CD) and compare it with that of the HDST results and serum DHEA-S level. Methods: We performed a retrospective, multicenter study from January 2000 to May 2012 involving 92 patients with endogenous CS. The levels of plasma ACTH, serum cortisol, 24-hour urine free cortisol (UFC) after the HDST, and serum DHEA-S were measured. Results: Fifty-seven patients had adrenal CS and 35 patients had CD. The area under the curve of plasma ACTH, serum DHEA-S, percentage suppression of serum cortisol, and UFC after HDST were 0.954, 0.841, 0.950, and 0.997, respectively (all P<0.001). The cut-off values for plasma ACTH, percentage suppression of serum cortisol, and UFC after HDST were 5.3 pmol/L, 33.3%, and 61.6%, respectively. The sensitivity and specificity of plasma ACTH measurement were 84.2% and 94.3%, those of serum cortisol were 95.8% and 90.6%, and those of UFC after the HDST were 97.9% and 96.7%, respectively. Conclusion: Significant overlap in plasma ACTH levels was seen between patients with adrenal CS and those with CD. The HDST may be useful in differentiating between these forms of the disease, especially when the plasma ACTH level alone is not conclusive.

      • KCI등재

        The Frequency and Clinical Implications of the BRAFV600E Mutation in Papillary Thyroid Cancer Patients in Korea Over the Past Two Decades

        홍아람,임정아,김태현,최훈성,유원상,민혜숙,원재경,이규은,정경천,박도준,박영주 대한내분비학회 2014 Endocrinology and metabolism Vol.29 No.4

        Background: Over the past several decades, there has been a rapid worldwide increase in the prevalence of papillary thyroid cancer (PTC) as well as a number of changes in the clinicopathological characteristics of this disease. BRAFV600E, which is a mutation of the proto-oncogene BRAF, has become the most frequent genetic mutation associated with PTC, particularly in Korea. Thus, the present study investigated whether the prevalence of the BRAFV600E mutation has increased over the past two decades in the Korean population and whether various PTC-related clinicopathological characteristics have changed. Methods: The present study included 2,624 patients who underwent a thyroidectomy for PTC during two preselected periods; 1995 to 2003 and 2009 to 2012. The BRAFV600E mutation status of each patient was confirmed using the polymerase chain reaction-restriction fragment length polymorphism method or by the direct sequencing of DNA. Results: The prevalence of the BRAFV600E mutation in Korean PTC patients increased from 62.2% to 73.7% (P=0.001) over the last two decades. Additionally, there was a greater degree of extrathyroidal extension (ETE) and lymph node metastasis in 2009 to 2012 patients with the BRAFV600E mutation and a higher frequency of thyroiditis and follicular variant-PTC in 2009 to 2012 patients with wild-type BRAF. However, only the frequency of ETE was significantly higher in 1995 to 2003 patients with the BRAFV600E mutation (P=0.047). Long-term recurrence rates during a 10-year median follow-up did not differ based on BRAFV600E mutation status. Conclusion: The BRAFV600E mutation rate in Korean PTC patients has been persistently high (approximately 70%) over the past two decades and continues to increase. The present findings demonstrate that BRAFV600E-positive PTC was associated with more aggressive clinicopathological features, especially in patients who were recently diagnosed, suggesting that BRAFV600E mutation status may be a useful prognostic factor for PTC in patients recently diagnosed with this disease.

      • KCI등재

        Characteristics of Korean Patients with Primary Adrenal Insufficiency: A Registry-Based Nationwide Survey in Korea

        홍아람,류옥현,김성연,김상완,The Korean Adrenal Gland and Endocrine Hypertension Study Group, Korea 대한내분비학회 2017 Endocrinology and metabolism Vol.32 No.4

        Background: Primary adrenal insufficiency (PAI) is a rare, potentially life-threatening condition. There are few Korean studies on PAI, and most have had small sample sizes. We aimed to examine the etiology, clinical characteristics, treatment, and mortality of PAI in Korean patients. Methods: A nationwide, multicenter, registry-based survey was conducted to identify adults diagnosed with or treated for PAI at 30 secondary or tertiary care institutions in Korea between 2000 and 2014. Results: A total of 269 patients with PAI were identified. The prevalence of PAI was 4.17 per million. The estimated incidence was 0.45 per million per year. The mean age at diagnosis was 49.0 years, and PAI was more prevalent in men. Adrenal tuberculosis was the most common cause of PAI in patients diagnosed before 2000; for those diagnosed thereafter, adrenal metastasis and tuberculosis were comparable leading causes. The etiology of PAI was not identified in 34.9% of cases. Of the patients receiving glucocorticoid replacement therapy, prednisolone was more frequently administered than hydrocortisone (69.4% vs. 26.5%, respectively), and only 27.1% of all patients received fludrocortisone. We observed an increased prevalence of metabolic disease and osteoporosis during the follow-up period (median, 60.2 months). The observed overall mortality and disease-specific mortality rates were 11.9% and 3.1%, respectively. Conclusion: The prevalence of PAI is significantly lower in Koreans than in reports from Western countries. The high frequency undetermined etiology in patients with PAI suggests the need to reveal accurate etiology of PAI in Korea.

      • KCI등재

        Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Korean Patients with Type 2 Diabetes Mellitus in Real-World Clinical Practice

        홍아람,구보경,김상완,이가희,문민경 대한당뇨병학회 2019 Diabetes and Metabolism Journal Vol.43 No.5

        Background: This study aimed to evaluate the efficacy and safety of sodium-glucose cotransporter-2 (SGLT2) inhibitors in Koreanpatients who had inadequately controlled type 2 diabetes mellitus (T2DM) in real-world clinical practice. Methods: We included 410 patients who started SGLT2 inhibitors (empagliflozin or dapagliflozin) as add-on therapy or switchtherapy between February 2015 and June 2017. The primary efficacy endpoint was a change in glycosylated hemoglobin (HbA1c)from baseline to week 12. The secondary endpoints were patients achieving HbA1c <7.0% and changes in the fasting plasma glucose(FPG), lipid profiles, body weight, and blood pressure (BP). Results: The mean HbA1c at baseline was 8.5% (8.6% in the add-on group and 8.4% in the switch group). At week 12, the mean adjustedHbA1c decreased by –0.68% in the overall patients (P<0.001), by –0.94% in the add-on group, and by –0.42% in the switchgroup. Significant reductions in FPG were also observed both in the add-on group and switch group (–30.3 and –19.8 mg/dL, respectively). Serum triglyceride (–16.5 mg/dL), body weight (–2.1 kg), systolic BP (–4.7 mm Hg), and diastolic BP (–1.3 mm Hg)were significantly improved in the overall patients. Approximately 18.3% of the patients achieved HbA1c <7.0% at week 12. A lowincidence of hypoglycemia and genital tract infection was observed (6.3% and 2.2%, respectively). Conclusion: SGLT2 inhibitors can be a suitable option as either add-on or switch therapy for Korean patients with inadequatelycontrolled T2DM.

      • KCI등재

        간호조직 내 정치와 갈등이 태움에 미치는 영향에 관한 실증연구

        홍아람,이선영,정종원 한국디지털정책학회 2019 디지털융복합연구 Vol.17 No.8

        본 연구목적은 대형 종합병원의 간호조직 내 정치와 갈등 지각정도를 파악하고, 조직 내 정치와 갈등이 간호조직 내 괴롭힘, 즉 태움에 어떠한 영향을 주고 있는지를 실증분석하는 것이다. 연구방법은 서울 A대학병원에서 근무하는 273명 간호사들을 대상으로 다중회귀분석을 실시하였다. 분석결과, 조직 내 정치 및 관계갈등은 간호조직 내 태움을 증폭시키고 있음을 확인할 수 있었다. 즉 간호조직 내 파벌이나 하위 집단 간 갈등, 따돌림, 구성원 간 감정적 갈등이 심화되면서, 태움 역시 증가하고 있음을 확인하였다. 본 연구가 탐색적 성격을 가진 만큼 향후 조직 내 정치, 갈등, 그리고 태움에 관한 연구가 본격화되어, 그 관리적 방안에 대한 진지한 고민과 실질적 함의를 모색할 것을 기대해본다. The purpose of this research is to identify the level of perception of conflict with politics within nursing organizations in large general hospitals, and to empirically analyze how politics and conflicts in the organization affect workplace bullying(taeoom) within nursing organizations. The research method conducted multiple regression analysis on 273 nurses working at A University Hospital in Seoul. The analysis shows that political and relationship conflicts within the organization are amplifying the workplace bullying within the nursing system. It was confirmed that taeoom was also increasing as conflicts between factions or subgroups within the nursing system, alienation, and emotional conflicts among members grew. We hope that the future research regarding taeoom will seek serious theoretical insights and practical implications for its management.

      • KCI등재

        Transformation of Mature Osteoblasts into Bone Lining Cells and RNA Sequencing-Based Transcriptome Profiling of Mouse Bone during Mechanical Unloading

        홍아람,김광수,이지연,양재연,김정희,신찬수,김상완 대한내분비학회 2020 Endocrinology and metabolism Vol.35 No.2

        Background: We investigated RNA sequencing-based transcriptome profiling and the transformation of mature osteoblasts intobone lining cells (BLCs) through a lineage tracing study to better understand the effect of mechanical unloading on bone loss. Methods: Dmp1-CreERt2(+):Rosa26R mice were injected with 1 mg of 4-hydroxy-tamoxifen three times a week starting at postnatal week 7, and subjected to a combination of botulinum toxin injection with left hindlimb tenotomy starting at postnatal week 8 to10. The animals were euthanized at postnatal weeks 8, 9, 10, and 12. We quantified the number and thickness of X-gal(+) cells onthe periosteum of the right and left femoral bones at each time point. Results: Two weeks after unloading, a significant decrease in the number and a subtle change in the thickness of X-gal(+) cells wereobserved in the left hindlimbs compared with the right hindlimbs. At 4 weeks after unloading, the decrease in the thickness was accelerated in the left hindlimbs, although the number of labeled cells was comparable. RNA sequencing analysis showed downregulation of 315 genes in the left hindlimbs at 2 and 4 weeks after unloading. Of these, Xirp2, AMPD1, Mettl11b, NEXN, CYP2E1, Bche,Ppp1r3c, Tceal7, and Gadl1 were upregulated during osteoblastogenic/osteocytic and myogenic differentiation in vitro. Conclusion: These findings demonstrate that mechanical unloading can accelerate the transformation of mature osteoblasts intoBLCs in the early stages of bone loss in vivo. Furthermore, some of the genes involved in this process may have a pleiotropic effecton both bone and muscle.

      • KCI등재

        Evaluation and Management of Bone Health in Patients with Thyroid Diseases: A Position Statement of the Korean Thyroid Association

        홍아람,강호철 대한내분비학회 2023 Endocrinology and metabolism Vol.38 No.2

        Thyroid hormones play an important physiological role in maintaining adult bone structure and strength. Consequently, thyroid dysfunction is related to skeletal outcomes. Overt hyperthyroidism is an established cause of high bone turnover with accelerated bone loss, leading to osteoporosis and increased fracture risk. Hyperthyroidism induced by thyroid-stimulating hormone-suppressive therapy in patients with differentiated thyroid cancer is a cause of secondary osteoporosis. In contrast, there is a lack of evidence on the negative impact of hypothyroidism on bone health. Considering the clinical updates on the importance of bone health in thyroid dysfunction, the Task Force from the Clinical Practice Guidelines Development Committee of the Korean Thyroid Association recently developed a position statement on the evaluation and management of bone health of patients with thyroid diseases, particularly focused on endogenous hyperthyroidism and thyroid-stimulating hormone-suppressive therapy-associated hyperthyroidism in patients with differentiated thyroid cancer. Herein, we review the Korean Thyroid Association’s position statement on the evaluation and management of bone health associated with thyroid diseases.

      • KCI등재후보

        갑상선암에서 BRAF 돌연변이의 임상적 의미

        홍아람,박영주,A Ram Hong,Young Joo Park 대한갑상선-내분비외과학회 2014 The Koreran journal of Endocrine Surgery Vol.14 No.3

        The BRAF<sup>V600E</sup> mutation is the most common genetic alteration and presents in 40∼80% of all papillary thyroid cancer (PTC), showing the highest prevalence in the Korean population, close to 80%. Previous studies published in the past 10 years showed a significant correlation between BRAF<sup>V600E</sup> mutation and poor prognostic outcomes of PTC, including recurrence and mortality. Therefore, its clinical application for the diagnosis of thyroid nodule or for decisions regarding the management policy by prediction of the prognosis of thyroid cancer has been proposed. However, some recent studies have reported conflict results, and there appear to be growing concerns regard to the cost-benefit of tests for detection of the BRAF<sup>V600E</sup> mutation. In this paper, we reviewed previous studies regarding the BRAF<sup>V600E</sup> mutation and attempted to evaluate the clinical implication of the BRAFV600E mutation in clinical practice.

      연관 검색어 추천

      이 검색어로 많이 본 자료

      활용도 높은 자료

      해외이동버튼